12-64485466-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PP3_Moderate
The NM_013254.4(TBK1):c.1201A>G(p.Lys401Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000964 in 1,556,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013254.4 missense
Scores
Clinical Significance
Conservation
Publications
- frontotemporal dementia and/or amyotrophic lateral sclerosis 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
- frontotemporal dementia with motor neuron diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- autoinflammation with arthritis and vasculitisInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBK1 | NM_013254.4 | c.1201A>G | p.Lys401Glu | missense_variant | Exon 10 of 21 | ENST00000331710.10 | NP_037386.1 | |
TBK1 | XM_005268809.2 | c.1201A>G | p.Lys401Glu | missense_variant | Exon 10 of 21 | XP_005268866.1 | ||
TBK1 | XM_005268810.2 | c.1201A>G | p.Lys401Glu | missense_variant | Exon 10 of 21 | XP_005268867.1 | ||
TBK1 | XR_007063071.1 | n.1300A>G | non_coding_transcript_exon_variant | Exon 10 of 18 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000441 AC: 1AN: 226572 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000926 AC: 13AN: 1404330Hom.: 0 Cov.: 22 AF XY: 0.0000129 AC XY: 9AN XY: 699258 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74312 show subpopulations
ClinVar
Submissions by phenotype
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 Pathogenic:1Uncertain:1
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3A. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (MIM#616439) (PMID: 27892983). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from lysine to glutamic acid. (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD <0.001 for a dominant condition (v3: 2 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v3; 1 heterozygote, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0601 - Variant is located in the annotated TANK-binding kinase 1 coiled-coil domain 1 where this residue p.(Lys401) is known to undergo poly-ubiquitination. It is one of two such sites required for kinase activity and signalling (DECIPHER, NCBI, PMID: 23453972). (SP) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0809 - Previous evidence of pathogenicity for this variant is inconclusive. This variant has been reported in an individual with a clinical diagnosis of Alzheimers disease and post mortem findings suggested frontotemporal dementia (PMID: 25943890). (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1010 - Functional evidence for this variant is conflicting. One study found this variant caused reduced TBK1 protein levels in post mortem brain tissue of an ALS patient, while another found it didn’t affect kinase activity, or protein stability and binding (PMID: 25943890, 31748271). (I) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at